Organization
Imago BioSciences
5 clinical trials
Clinical trial
A Multi-Center, Open Label, Extension Study Evaluating the Safety and Efficacy of Bomedemstat for the Treatment of Patients With Myeloproliferative Neoplasms (MPNs) Enrolled in a Prior Bomedemstat Clinical StudyStatus: Active (not recruiting), Estimated PCD: 2024-08-22
Clinical trial
A Multi-Center, Open Label Study to Assess the Safety, Steady-State Pharmacokinetics and Pharmacodynamics of IMG-7289 in Patients With MyelofibrosisStatus: Completed, Estimated PCD: 2022-03-08
Clinical trial
A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bomedemstat in Patients With Polycythemia Vera (PV)Status: Active (not recruiting), Estimated PCD: 2025-03-24
Clinical trial
A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy and Pharmacodynamics of IMG-7289 in Patients With Essential ThrombocythemiaStatus: Completed, Estimated PCD: 2023-03-23
Clinical trial
A Multi-Center, Open Label Study to Assess the Safety, Steady-State Pharmacokinetics and Pharmacodynamics of IMG-7289 With and Without ATRA (Tretinoin) in Patients With Advanced Myeloid MalignanciesStatus: Completed, Estimated PCD: 2018-10-30